Acute coronary syndromes: consensus recommendations for translating knowledge into action

Stephen P Fitzgerald
Med J Aust 2010; 193 (1): . || doi: 10.5694/j.1326-5377.2010.tb03757.x
Published online: 5 July 2010

To the Editor: It seems that the perceived value of invasive therapy for different acute coronary syndromes varies according to how one chooses and values the various trials.1-3 The differing opinions may have been enriched had they not only considered short-term cardiovascular outcome but also weighed quantitatively — in absolute terms — the purported benefits (or lack thereof) of invasive therapy against the immediate complications and the long-term risks and burden of the combined aspirin and clopidogrel antiplatelet therapy usually necessary after stent placement. It may be that with all this information, patients also have a range of opinions regarding benefits and risks.4

  • Stephen P Fitzgerald

  • Royal Adelaide Hospital, Adelaide, SA.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.